Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genzyme Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3407
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis, Gaucher disease type 1, long-term enzyme replacement therapy, acute lymphoblastic leukemia, atopic dermatitis, management of uric acid levels, fabry disease, rheumatoid arthritis, Pompe disease, non-Hodgkin’s lymphoma, multiple myleoma, gastric adenocarcinoma and squamous cell carcinoma, and kidney transplant acute rejection. The company has several more products in various stages of development. It operates a research and development lab and manufacturing plants in the US, Belgium and Ireland. The company has presence across the world. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Venture Financing 15
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Partnerships 19
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Merger 30
Sanofi Japan and Genzyme Japan Merge 30
Licensing Agreements 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Equity Offering 33
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Asset Transactions 36
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp – Key Competitors 37
Genzyme Corp – Key Employees 38
Genzyme Corp – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 41
Recent Developments 42
Clinical Trials 42
Apr 11, 2017: Sanofi Genzyme to present data on GLD52 (GZ402668) at AAN 42
Feb 14, 2017: Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease 43
Other Significant Developments 44
Mar 22, 2017: Sanofi Genzyme Extends Its Multiple Myeloma Journey Partners Program To Cities Nationwide To Help Improve Patient Outcomes Through Peer-to-Peer Education 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Genzyme Corp, Pharmaceuticals & Healthcare, Key Facts 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Sanofi Japan and Genzyme Japan Merge 30
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp, Key Competitors 37
Genzyme Corp, Key Employees 38
Genzyme Corp, Other Locations 39
Genzyme Corp, Subsidiaries 39
Genzyme Corp, Joint Venture 41

List of Figures
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Sembcorp Industries Ltd (U96)-エネルギー分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • TransCanada Corp:企業の戦略・SWOT・財務情報
    TransCanada Corp - Strategy, SWOT and Corporate Finance Report Summary TransCanada Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Mechanics Bank:企業の戦略・SWOT・財務情報
    Mechanics Bank - Strategy, SWOT and Corporate Finance Report Summary Mechanics Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • Dome Energy AB (DOME):石油・ガス:M&Aディール及び事業提携情報
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • Nuh Cimento Sanayi AS (NUHCM):企業の財務・戦略的SWOT分析
    Nuh Cimento Sanayi AS (NUHCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nakheel:企業の戦略・SWOT・財務分析
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • IndiPharm Inc-製薬・医療分野:企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • Acobiom:企業の製品パイプライン分析2018
    Summary Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companio …
  • The Tokyo Star Bank Ltd:企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Salem Media Group, Inc.:企業の戦略・SWOT・財務情報
    Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Anpario Plc (ANP):企業の財務・戦略的SWOT分析
    Summary Anpario Plc (Anpario), formerly Kiotech International Plc is a producer and distributor of natural feed additives for animal health, hygiene and nutrition. The company develops products for poultry, pig, ruminant and animal feed markets that include acidifiers, essential oils, enzymes, pelle …
  • Leukemia & Lymphoma Society Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, an …
  • Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and …
  • WPPI Energy, Inc.:企業の戦略的SWOT分析
    WPPI Energy, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Corvel Corporation
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆